Karel Doorman

Karel is focused on investments in technology and tech-enabled services businesses. He is a member of the TMT and Business Services sector teams and a member of the Benelux regional team. Karel has previously been a part of the Consumer and Healthcare sector teams, and has been involved in a number of transactions, including Barentz, Clario (formerly Bioclinica), JLA and RB Iberia.

Prior to joining Cinven, Karel worked at Credit Suisse as a member of the EMEA Financial Institutions Group in London, where he advised on M&A and IPO transactions.

Karel has a Masters in Financial Economics from the Erasmus University Rotterdam in the Netherlands.

He joined Cinven in 2015